CVS is reportedly considering buying health insurance giant Aetna for $86 billion

  • CVS Health is in talks with health insurer Aetna about a possible acquisition.
  • The deal would value Aetna at around $US66 billion ($AU86 billion), or roughly $US200 ($AU261) per share.
  • The news comes less than a year after a judge blocked Aetna’s attempt to acquire rival insurer Humana on anti-competitive grounds.


CVS Health
, the retail pharmacy giant, is in talks to purchase Aetna, one of the five large publicly-traded health insurance companies, according to a new report.

The Wall Street Journal’s Dana Mattioli reported that CVS offered more than $US200 per share of Aetna, which was currently at $US160 a share before the news broke. The deal would be worth around $US66 billion according to the report.

Aetna previously agreed to buy rival insurer Humana for $US37 billion, but that deal was blocked by the Department of Justice. A judge ruled in favour of the DOJ in January, saying that the combination of the two companies would have been anti-competitive.

An Aetna spokesperson declined to comment on the report, telling Business Insider, “We don’t comment on rumours or speculation.”

A spokesperson for CVS was not immediately available for comment.

Following the news, Aetna shares jumped around 11.5% to $US178.60 a share as of 4:15 p.m. ET. CVS shares slipped by roughly 3% to $US72.60 a share.

NOW WATCH: Money & Markets videos

Want to read a more in-depth view on the trends influencing Australian business and the global economy? BI / Research is designed to help executives and industry leaders understand the major challenges and opportunities for industry, technology, strategy and the economy in the future. Sign up for free at research.businessinsider.com.au.